{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05452",
      "entity_text" : "TN",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:AKT",
      "entity_text" : "AKT",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The high failure rate with EGFR inhibitors relatively to the frequent overexpression may be due to the absence of pathway activation (EGFR gene amplification is rare) or the existence of alternative activation pathways such as the frequently observed PTEN inactivation and AKT activation in TN breast cancers.",
  "reading_complete" : "2020-07-28T14:31:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:17:50Z",
  "trigger" : "activation",
  "evidence" : [ "AKT activation in TN" ],
  "pmc_id" : "3343384",
  "score" : 0
}